CN112826090A - 一种提高耐力的运动营养片剂及其制备方法 - Google Patents
一种提高耐力的运动营养片剂及其制备方法 Download PDFInfo
- Publication number
- CN112826090A CN112826090A CN202110088498.1A CN202110088498A CN112826090A CN 112826090 A CN112826090 A CN 112826090A CN 202110088498 A CN202110088498 A CN 202110088498A CN 112826090 A CN112826090 A CN 112826090A
- Authority
- CN
- China
- Prior art keywords
- endurance
- sports
- vitamin
- tablet
- exercise
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000014268 sports nutrition Nutrition 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims abstract description 6
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 16
- 235000016709 nutrition Nutrition 0.000 claims abstract description 12
- 241000209140 Triticum Species 0.000 claims abstract description 7
- 235000021307 Triticum Nutrition 0.000 claims abstract description 7
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 6
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 6
- 229940088594 vitamin Drugs 0.000 claims abstract description 6
- 229930003231 vitamin Natural products 0.000 claims abstract description 6
- 235000013343 vitamin Nutrition 0.000 claims abstract description 6
- 239000011782 vitamin Substances 0.000 claims abstract description 6
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 14
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 14
- 239000008103 glucose Substances 0.000 claims description 14
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 12
- 229960002477 riboflavin Drugs 0.000 claims description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- 229930003451 Vitamin B1 Natural products 0.000 claims description 10
- 229930003471 Vitamin B2 Natural products 0.000 claims description 10
- 229960003495 thiamine Drugs 0.000 claims description 10
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 10
- 235000010374 vitamin B1 Nutrition 0.000 claims description 10
- 239000011691 vitamin B1 Substances 0.000 claims description 10
- 235000019164 vitamin B2 Nutrition 0.000 claims description 10
- 239000011716 vitamin B2 Substances 0.000 claims description 10
- 230000002708 enhancing effect Effects 0.000 claims description 6
- 239000011812 mixed powder Substances 0.000 claims description 6
- 238000007873 sieving Methods 0.000 claims description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 5
- 229930003268 Vitamin C Natural products 0.000 claims description 5
- 235000019154 vitamin C Nutrition 0.000 claims description 5
- 239000011718 vitamin C Substances 0.000 claims description 5
- 229930091371 Fructose Natural products 0.000 claims description 4
- 239000005715 Fructose Substances 0.000 claims description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 claims description 3
- 239000006185 dispersion Substances 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 239000004376 Sucralose Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 235000019359 magnesium stearate Nutrition 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 2
- 235000019408 sucralose Nutrition 0.000 claims description 2
- 235000013361 beverage Nutrition 0.000 claims 1
- 230000004060 metabolic process Effects 0.000 abstract description 10
- 230000003647 oxidation Effects 0.000 abstract description 10
- 238000007254 oxidation reaction Methods 0.000 abstract description 10
- 239000000126 substance Substances 0.000 abstract description 7
- 206010021036 Hyponatraemia Diseases 0.000 abstract description 5
- 230000035764 nutrition Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 14
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 12
- 239000011734 sodium Substances 0.000 description 12
- 229910052708 sodium Inorganic materials 0.000 description 12
- 210000003205 muscle Anatomy 0.000 description 11
- 235000014633 carbohydrates Nutrition 0.000 description 10
- 229920002527 Glycogen Polymers 0.000 description 9
- 229940096919 glycogen Drugs 0.000 description 9
- 230000001965 increasing effect Effects 0.000 description 9
- 235000000346 sugar Nutrition 0.000 description 8
- 108090000765 processed proteins & peptides Proteins 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 235000002639 sodium chloride Nutrition 0.000 description 5
- 239000013589 supplement Substances 0.000 description 5
- 208000029549 Muscle injury Diseases 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 3
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 3
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 3
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 3
- 229940013640 flavin mononucleotide Drugs 0.000 description 3
- 239000011768 flavin mononucleotide Substances 0.000 description 3
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 3
- FVTCRASFADXXNN-UHFFFAOYSA-N flavin mononucleotide Natural products OP(=O)(O)OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-UHFFFAOYSA-N 0.000 description 3
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000036542 oxidative stress Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 235000019231 riboflavin-5'-phosphate Nutrition 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000012549 training Methods 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229940100228 acetyl coenzyme a Drugs 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000037080 exercise endurance Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 210000000663 muscle cell Anatomy 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 229960002363 thiamine pyrophosphate Drugs 0.000 description 2
- 235000008170 thiamine pyrophosphate Nutrition 0.000 description 2
- 239000011678 thiamine pyrophosphate Substances 0.000 description 2
- YXVCLPJQTZXJLH-UHFFFAOYSA-N thiamine(1+) diphosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N YXVCLPJQTZXJLH-UHFFFAOYSA-N 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 2
- 150000003628 tricarboxylic acids Chemical class 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- 230000002407 ATP formation Effects 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- 206010048962 Brain oedema Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010049565 Muscle fatigue Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 230000009056 active transport Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000008784 apnea Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 208000006752 brain edema Diseases 0.000 description 1
- 230000034149 carbohydrate storage Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 230000004116 glycogenolysis Effects 0.000 description 1
- 230000002414 glycolytic effect Effects 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000005787 mitochondrial ATP synthesis coupled electron transport Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000020733 paullinia cupana extract Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 235000013997 pineapple juice Nutrition 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229940076788 pyruvate Drugs 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000035806 respiratory chain Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000002363 skeletal muscle cell Anatomy 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000009184 walking Effects 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种提高耐力的运动营养片剂及其制备方法,其中营养片剂包括下述重量百分含量的组分:糖类10~47%,小麦低聚肽40~70%,复合维生素0.1~0.61%,盐12~20%。本发明运动营养片剂,携带方便,食用方便,可以提高新陈代谢,促进能源物质参与有氧氧化,加快机体产生能量的速度,降低疲劳感,预防低钠血症,提升耐力素质。
Description
技术领域
本发明涉及运动营养食品领域,具体涉及一种提高耐力的运动营养片剂及其制备方法。
背景技术
耐力性运动包括中长跑、慢跑、快走、自行车、游泳、划船、有氧健身操、舞蹈、户外运动等。这些项目的运动强度相对较小、持续时间相对较长,运动所需能量主要来源于能源物质的有氧氧化,运动过程中能源物质(尤其是肌糖原)含量减少,体液丢失,电解质紊乱,体温升高,代谢失调等是影响耐力训练效果和耐力比赛成绩的主要因素。在运动型运动中,如果不对以上问题进行解决,就会造成人体机能下降,机体产生氧化应激状态,无法充分恢复疲劳,影响运动效果。
近年来关于提高耐力的研究备受关注,CN112021573A中公开了一种提高耐力的运动营养组合物,主要成分是碳水化合物、水溶性膳食纤维和复合维生素,主要补充人体所需营养,提高人体耐力、快速消除疲劳。但其未能补充在耐力运动中极易流失的电解质,特别是钠的补充,同时未提及对肌肉损伤修复等问题。
CN111789254A中公开了一种运动耐力类运动营养食品配方,主要成分是低聚麦芽糖、葡萄糖、白砂糖、海藻糖、左旋肉碱、凤梨果汁粉、柠檬酸、氯化钾、瓜拉纳提取物(0.8%)、氧化镁、食用盐、泛酸、烟酸、维生素B1、维生素B6、维生素B2,补充各种营养素,通过糖提供能量,同时添加左旋肉碱,促进脂肪代谢,但未提及对肌肉损伤修复等问题,同时未提及动物或人体试食报告,因此并不知道该配方提升耐力的应用效果情况。目前对肽类的提升耐力研究较多,但大多是集中于大豆肽、牛奶肽、乳清蛋白肽等,但对小麦低聚肽提升耐力的应用研究很少。
运动营养食品是为满足运动人群(指每周参加体育锻炼3次及以上、每次持续时间30min及以上、每次运动强度达到中等及以上的人群)的生理代谢状态、运动能力及对某些营养成的特殊需求而专门加工的食品。目前市面上的运动营养食品大部分是液体类或固体冲调类产品,片剂具有体积小、携带方便、不用水冲调等特点,特别适合运动人群的需要。因此,将运动营养与片剂有效结合起来,将会是人们健康消费的一个新趋势。
发明内容
为了弥补现有技术中存在的不足,本发明提供了一种提高耐力的运动营养片剂,可以提高新陈代谢,促进能源物质参与有氧氧化,加快机体产生能量的速度,降低疲劳感,预防低钠血症,且携带和食用方便。
为了达到上述目的,本发明采用的技术方案如下:
一种提高耐力的运动营养片剂,包括下述重量百分含量的组分:糖类10~47%,小麦低聚肽40~70%,复合维生素0.1~0.61%,盐12~20%。
进一步的,所述糖类包括重量百分比为10~47%的葡萄糖、0~40%非葡萄糖类,所述非葡萄糖类为果糖、低聚麦芽糖、蔗糖中的一种或几种。
进一步的,所述复合维生素包括维生素B1、维生素B2、维生素C。
进一步的,所述维生素B1和维生素B2的重量百分含量比为(0.5~2)∶1。
进一步的,本发明的提高耐力的运动营养片剂还包括以下重量百分含量的组分,硬脂酸镁0.1~1%,三氯蔗糖0.5~1.5%。
此外,本发明还提供了上述提高耐力的运动营养片剂的制备方法,包括以下步骤:
S1、按重量百分含量称取各组分,并将各组分中水分的质量百分含量控制在5%以下;
S2、将各组分过40目筛进行分散,如不能过筛的则粉碎过40目筛;
S3、将过筛后的各组分采用三维运动混合机混合40min,得混合粉;
S4、将所得混合粉进行压片,制得提高耐力的运动营养片剂。
进一步的,上述步骤S3中,将三维运动混合机的转速设定为8转/分钟。
相对于现有技术,本发明具有以下有益技术效果:
(一)在长时间的有氧耐力运动的初期,肌糖原提供了大部分碳水化合物来为人体活动提供能量,肌糖原是身体中碳水化合物的主要存储形式。但是人体的肌糖原的储量有限,当肌糖原消耗殆尽,它就不能为人体活动提供能量。实际上,在通常情况下,经过训练的运动员体内的肌糖原最多只能维持数小时的运动。血糖成为提供维持活动所需的能量的重要物质,血糖的下降将会使大脑对运动的调节能力减弱,从而造成中枢疲劳。低水平的肌糖原除了可能会降低运动表现,还与蛋白质降解,肌糖原分解下降,兴奋-收缩耦联(使肌细胞收缩的过程)受限相关。提高血糖水平,促进碳水化合物氧化,可以帮助减少有氧耐力训练期间的疲劳,碳水化合物氧化(代谢)的提高可以减少对有限的内部碳水化合物储存量的依赖。因此,一个人能够氧化(代谢)的碳水化合物越多,就可以越多地氧化补充性碳水化合物,并因此节省了肌糖原。碳水化合物的类型也对运动表现和碳水化合物氧化速率有影响,碳水化合物通常以糖类为主,糖类又以葡萄糖、果糖、蔗糖、低聚糖为主。
本发明以葡萄糖为主,添加或不添加其它糖类(果糖、蔗糖、低聚糖)中的一种或几种。葡萄糖吸收最快,能快速补充肌糖原,同时补充几种糖源,每种糖源有不同的肠道传输机制,能加快碳水化合的氧化速率。
(二)维生素B1、维生素B2,可以提高新陈代谢,提高有氧氧化酶的活性,进而促进能源物质参与有氧氧化,加快机体产生能量的速度。
维生素B1与葡萄糖转化成五碳糖有关,而五碳糖是核酸(DNA)合成所需的碳架。维生素B1以焦磷酸硫胺素的形式催化丙酮酸脱羧,生成乙酰辅酶A,然后进入三羧酸循环。当进行耐力运动时,能量代放提高,乙酰辅酶A的水平也相应的提升,从而导致运动人群容易出现维生素B1缺乏的现象,一旦体内缺乏维生素B1,糖的氧化供能受阻,糖代谢中间产物-丙酮酸堆积,无法生成三羧酸循环所必需的乙酰辅酶A,导致三磷酸腺苷ATP产生速率减慢,同时,也导致神经冲动的传导减慢;维生素B1不足也会使另一代谢中间产物堆积-乳酸,而乳酸堆积是导致疲劳出现的原因之一;维生素B1缺乏时,也会引起琥珀酸及血红素原料的利用率降低,影响血红蛋白的生成,导致红细胞摄氧能力下降,进而使得耐力运动员有氧运动能力下降。焦磷酸硫胺素是糖和氨基酸代谢的辅酶,焦磷酸硫胺素除了有调节新陈代谢的作用,还有保护神经系统的作用,并且还可以促进肠胃蠕动,提高食欲。
维生素B2在线粒体电子传递系统中起着非常重要的作用,它除了对有氧耐力很重要外,还可以影响糖酵解系统,从而影响无氧代谢供能能力。维生素B2的需要量与能量代谢密切相关,研究表明,运动员的维生素B2需求量高于普通人群。核黄素作为一些生理反应的辅酶,意味着这些代谢途径需要维生素B2才能进行正常的工作。具体来说,黄素单核苷酸(FMN)和黄素腺嘌呤二核苷酸(FAD)作为辅酶因子作用于各种涉及核黄蛋白的反应,比如FMN和FAD在线粒体内的三羧酸循环中扮演着至关重要的作用,进而调控ATP的生成速度。
(三)运动时机体能量需求量迅速增加,新陈代谢旺盛,骨骼肌细胞的耗氧量增加100-200倍,此时组织中自由基的生成也随之增加。随着运动强度和时间的增加,自由基的产生急剧增多,且超过了机体自身清除自由基的能力,组织抗氧化能力下降,机体产生氧化应激状态。运动性氧化应激是组织损伤、肌肉疲劳的主要原因之一。自由基生成增加导致身体功能状况下降和运动疲劳产生的原因可能是:自由使细胞膜和其他生物膜发生脂质过氧化损伤,从而改变膜的流动性、通透性和完整性,进而使细胞以及亚细胞器的功能紊乱;自由基攻击机体的生物大分子(如蛋白质、DNA等),使蛋白质、DNA的结构受到破坏、功能丧失;使呼吸链的功能下降等。
因此,补充抗氧化剂以对抗运动中生成的大量自由基是延缓运动性疲劳的发生、促进运动后疲劳的消除和身体功能恢复的重要手段之一。维生素C是目前体育界比较常用而且有效的抗氧化剂。而且人体需要使用维生素C来合成儿茶酚胺和肉碱,肉碱可以将脂肪转运到线粒体来产生能量。
(四)肽是蛋白质的结构片段,是氨基酸的有机合成物,也是蛋白质的水解产物,其相对分子质量比蛋白质分子小很多,生物活性非常高。肽类具有吸收快、耗能低、不易饱和特点。小肠状缘上存在二肽和三肽转运转运系统,此类吸收系统是继发性主动转运。
小麦低聚肽是小麦蛋白经生物酶水解获得的小分子生物活性肽,进行循环系统后,可进一步分解为氨基酸,作为能源物质通过三羧酸循环来产生ATP;可以调节新陈代谢,促进蛋白质、氨基酸的合成,为机体修复受损组织提供稳定、充足的氮源,促进肌肉合成,预防修复肌肉损伤;可有效清除自由基,抑制脂质过氧化,具有抗疲劳活性;同时对肌细胞有一定保护作用,可显著改善运动员睾酮和皮质醇分泌失调,从而促进机体疲劳的恢复。
(五)钠是最重要的电解质,因为运动期间流失最多的就是钠。而且钠对于保持水合和血浆容量至关重要。当人体内钠的含量较低时,通过尿液流失的体液就会增加,这就对体液平衡带来不利影响。在通常情况下,人体汗液的钠含量为10-70毫升当量/升,但这些值会发生较大波动,其随出汗增加而升高,在训练适应和热适应后下降,在通常情况下,出汗率高的人,体内的钠的需要量就高。在长时间运动中,如果不能补充足够的钠,那么缺钠就会变成一个更严重的问题。与运动相关的低钠血症指的是血液中钠的浓度降低,对有氧耐力运动而言,这是一种常见症状,其体征和症状包括迷糊、目眩、头疼、恶心、呕吐和肌肉无力。如果不予治疗,低钠血症很快就会加剧并引起癫痫、脑水肿、昏迷、肺水肿和心跳呼吸骤停。因此对于长时间耐力运动的人群,需补充充足的盐分,特别是受出汗的人更应该补充充足的盐分。
本发明重量百分含量食盐达到12-20%,高含量钠,可补充较多长时间耐力运动流失的钠,预防低钠血症。
具体实施方式
在下面的描述中阐述了很多具体细节以便于充分理解本发明。但是本发明能够以很多不同于此描述的其他方式来实施,本领域技术人员可以在不违背本发明内涵的情况下做类似推广,因此本发明不受下面公开的具体实施例的限制。
表1实施例1-5的一种提高耐力运动营养片剂
实施例1-5的一种提高耐力运动营养片剂的制备方法如下:
S1、按重量百分含量称取各组分,并将各组分中水分的质量百分含量控制在5%以下;
S2、将各组分过40目筛进行分散,如不能过筛的则粉碎过40目筛;
S3、将过筛后的各组分采用三维运动混合机混合40min,三维运动混合机的转速设定为8转/分钟,得混合粉;
S4、将所得混合粉进行压片,制得提高耐力的运动营养片剂。
上述各实施例中,在具体制备时,实施例1-3压片规格为1g/片,实施例4-5压片规格为0.6g/片。
一种提高耐力运动营养片剂的应用效果实验例
1.1实验对象
招募70名爱好运动,经常运动的健康男性(年龄20-28岁)为研究对象。
1.2实验方法
70名受试者随机分为7组,每组10人。
空白组服用安慰剂(麦芽糊精),25g/天;
对照组服用CN112021573A中公开的组合物,25g/天。
例1组服用本发明专利实施例1的片剂,1g/片,8片/天,
例2组服用本发明专利实施例2的片剂,1g/片,8片/天;
例3组服用本发明专利实施例3的片剂,1g/片,8片/天;
例4组服用本发明专利实施例4的片剂,0.6g/片,8片/天;
例5组服用本发明专利实施例5的片剂,0.6g/片,8片/天。
测试方法1:食用第一天,慢跑2小时进行测试,分别记录心率、运动中主观疲劳感觉RPE,计算各组平均值;
测试方法2:连续服用4周后,慢跑2小时进行测试,分别记录心率、运动中主观疲劳感觉RPE,计算各组平均值,整个实验期间禁服其他提高耐力的食品和药品。
1.3实验结果
(1)心率
表2心率比较
从表2可以看出,本发明提供的提高耐力的运动营养组合物能够恢复心率,特别是长时间服用,效果更显著,说明受试者的运动耐力明显提高,运动能力加强,抗疲劳效果明显优于空白组和对照组。
(2)运动中主观疲劳感觉RPE
RPE是反映机体疲劳感的主观感觉指标。现一般采用Borg分值表进行记录。
表3Borg分值
表4运动中主观疲劳感觉RPE比较
空白组在测试后,绝大多数人都感觉筋疲力尽,头沉,呼吸困难,腿酸痛,肩膀酸。对照组在测试后疲劳感有所改善,但是大部分受试者有疲劳感,很累。实施例1-5组测试后感到明显疲乏的人数,远远低于对照组。特别是在长时间服用后,2小时慢跑后期,只是感到稍累,并没有头沉,呼吸不适等,说明实施例中的小麦低聚肽、维生素C能很好的提高运动耐力,清除自由基,预防修复肌肉损伤,促进机体疲劳的恢复。
以上仅为本发明的优选实施例而已,并不用于限制本发明,尽管参照实施例对本发明进行了详细的说明,对于本领域的技术人员来说,其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换,但是凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (7)
1.一种提高耐力的运动营养片剂,其特征在于,包括下述重量百分含量的组分:糖类10~47%,小麦低聚肽40~70%,复合维生素0.1~0.61%,盐12~20%。
2.根据权利要求1所述的提高耐力的运动营养片剂,其特征在于:所述糖类包括重量百分比为10~47%的葡萄糖、0~40%非葡萄糖类,所述非葡萄糖类为果糖、低聚麦芽糖、蔗糖中的一种或几种。
3.根据权利要求2所述的提高耐力的运动营养片剂,其特征在于:所述复合维生素包括维生素B1、维生素B2、维生素C。
4.根据权利要求3所述的提高耐力的运动营养片剂,其特征在于:所述维生素B1和所述维生素B2的重量百分含量比为(0.5~2)∶1。
5.根据权利要求1-4任一项所述的提高耐力的运动营养片剂,其特征在于:还包括以下重量百分含量的组分,硬脂酸镁0.1~1%,三氯蔗糖0.5~1.5%。
6.根据权利要求1-5任一项所述的提高耐力的运动营养片剂的制备方法,其特征在于,包括以下步骤:
S1、按重量百分含量称取各组分,并将各组分中水分的质量百分含量控制在5%以下;
S2、将各组分过40目筛进行分散,如不能过筛的则粉碎过40目筛;
S3、将过筛后的各组分采用三维运动混合机混合40min,得混合粉;
S4、将所得混合粉进行压片,制得提高耐力的运动营养片剂。
7.根据权利要求7所述的提高耐力的运动营养片剂的制备方法,其特征在于:所述步骤S3中,将三维运动混合机的转速设定为8转/分钟。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110088498.1A CN112826090A (zh) | 2021-01-22 | 2021-01-22 | 一种提高耐力的运动营养片剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110088498.1A CN112826090A (zh) | 2021-01-22 | 2021-01-22 | 一种提高耐力的运动营养片剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112826090A true CN112826090A (zh) | 2021-05-25 |
Family
ID=75930903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110088498.1A Pending CN112826090A (zh) | 2021-01-22 | 2021-01-22 | 一种提高耐力的运动营养片剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112826090A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101209106A (zh) * | 2006-12-30 | 2008-07-02 | 可口可乐公司 | 一种含有糖和肽的组合物及用途 |
CN103704808A (zh) * | 2013-12-14 | 2014-04-09 | 长泰县兴立食品技术研发中心 | 一种盐乐运动饮料及其制备工艺 |
CN106666303A (zh) * | 2016-11-15 | 2017-05-17 | 昆山国元生物科技有限公司 | 含大豆肽的维生素运动饮料 |
CN109430669A (zh) * | 2018-12-25 | 2019-03-08 | 江苏艾兰得营养品有限公司 | 提高耐力补充运动所需营养的泡腾片制剂及其制备方法 |
CN112021573A (zh) * | 2020-05-26 | 2020-12-04 | 上海轻姿健康管理有限公司 | 一种提高耐力的运动营养组合物 |
-
2021
- 2021-01-22 CN CN202110088498.1A patent/CN112826090A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101209106A (zh) * | 2006-12-30 | 2008-07-02 | 可口可乐公司 | 一种含有糖和肽的组合物及用途 |
CN103704808A (zh) * | 2013-12-14 | 2014-04-09 | 长泰县兴立食品技术研发中心 | 一种盐乐运动饮料及其制备工艺 |
CN106666303A (zh) * | 2016-11-15 | 2017-05-17 | 昆山国元生物科技有限公司 | 含大豆肽的维生素运动饮料 |
CN109430669A (zh) * | 2018-12-25 | 2019-03-08 | 江苏艾兰得营养品有限公司 | 提高耐力补充运动所需营养的泡腾片制剂及其制备方法 |
CN112021573A (zh) * | 2020-05-26 | 2020-12-04 | 上海轻姿健康管理有限公司 | 一种提高耐力的运动营养组合物 |
Non-Patent Citations (1)
Title |
---|
常映明: "《抗衰老漫谈 点燃生日蛋糕上的第120根蜡烛》", 30 November 2017, 中国医药科技出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2641667C (en) | Composition for optimizing muscle performance during exercise | |
US8168241B2 (en) | Performance-enhancing dietary supplement | |
CN100502692C (zh) | 一种体力恢复保健食品及其制备方法 | |
US20030143311A1 (en) | Recovery drink formula and method | |
BR0011277B1 (pt) | bebida desportiva compreendendo micronutrientes em combinação com aditivos convencionais para bebidas desportivas, tablete para a preparação de uma bebida desportiva e uso de lactobacilos. | |
WO2012068431A1 (en) | Performance enhancing sports beverage and methods of use | |
CN108651998A (zh) | 一种具有缓解疲劳功能的乳清蛋白粉及其制备方法 | |
CN112137095A (zh) | 一种运动营养组合物及其制备方法 | |
EP2910131B1 (en) | Anti-fatigue composition and use thereof | |
CN103750143A (zh) | 耐缺氧型抗疲劳能量组合物及其应用 | |
CN103766736A (zh) | 抗疲劳能量组合物及其应用 | |
CN108606269B (zh) | 一种运动型营养补充剂及其制备方法 | |
CN108013299A (zh) | 补充体能饮料 | |
CN103919052A (zh) | 用于体能恢复的组合物及其应用 | |
CN110801018A (zh) | 辅酶q10维生素c运动含片 | |
US20030104107A1 (en) | Energy drink formula and method | |
CN112021573A (zh) | 一种提高耐力的运动营养组合物 | |
CN113854566A (zh) | 一种营养补充剂 | |
CN106509540A (zh) | 一种增加免疫力并提高运动能力的饮料 | |
KR100549697B1 (ko) | 무산소 상태에서 순간적인 임팩트 파워를 증대 시키는 아미노산 건강기능식품 | |
RU2529155C1 (ru) | Шоколад для спортивного питания "шокоспорт" | |
CN112826090A (zh) | 一种提高耐力的运动营养片剂及其制备方法 | |
CN114403333A (zh) | 一种防中暑抗疲劳的泡腾片及其制备方法 | |
CN106723027A (zh) | 一种耐缺氧的营养组合物及其应用 | |
EP3984378A1 (en) | Dietary supplement for sport use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210525 |